Phibro Animal Health Corporation (NASDAQ:PAHC) issued its quarterly earnings data on Wednesday. The company reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.04, Bloomberg Earnings reports. Phibro Animal Health Corporation had a return on equity of 54.68% and a net margin of 8.49%. The company had revenue of $194.84 million during the quarter, compared to analysts’ expectations of $192.47 million. During the same quarter in the previous year, the company posted $0.32 earnings per share. The business’s revenue was up 3.0% on a year-over-year basis. Phibro Animal Health Corporation updated its FY18 guidance to $1.55-1.61 EPS.

Shares of Phibro Animal Health Corporation (PAHC) opened at 37.75 on Thursday. The firm has a market capitalization of $1.50 billion, a P/E ratio of 23.45 and a beta of 1.35. Phibro Animal Health Corporation has a 52-week low of $20.14 and a 52-week high of $40.25. The stock has a 50 day moving average of $38.56 and a 200-day moving average of $33.09.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a $0.10 dividend. The ex-dividend date is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.06%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

A number of brokerages have recently issued reports on PAHC. Piper Jaffray Companies set a $42.00 price objective on Phibro Animal Health Corporation and gave the stock a “buy” rating in a report on Friday, August 25th. Bank of America Corporation restated an “underperform” rating and set a $33.00 price objective on shares of Phibro Animal Health Corporation in a report on Wednesday, August 23rd. BidaskClub cut Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 23rd. Credit Suisse Group cut Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and boosted their price objective for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. Finally, Zacks Investment Research upgraded Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective for the company in a report on Thursday, May 11th. Three research analysts have rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $31.86.

In other Phibro Animal Health Corporation news, VP Daniel M. Bendheim sold 4,976 shares of the company’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $40.01, for a total value of $199,089.76. Following the completion of the transaction, the vice president now directly owns 4,176 shares in the company, valued at $167,081.76. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, major shareholder Bfi Co., Llc sold 48,000 shares of the company’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $34.82, for a total transaction of $1,671,360.00. Following the completion of the transaction, the insider now owns 96,000 shares of the company’s stock, valued at $3,342,720. The disclosure for this sale can be found here. Over the last quarter, insiders sold 268,657 shares of company stock valued at $9,802,503. Company insiders own 48.09% of the company’s stock.

Several institutional investors have recently modified their holdings of PAHC. Mason Street Advisors LLC raised its position in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares in the last quarter. State of Alaska Department of Revenue raised its position in shares of Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock worth $136,000 after buying an additional 1,650 shares in the last quarter. Municipal Employees Retirement System of Michigan raised its position in shares of Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock worth $162,000 after buying an additional 150 shares in the last quarter. Finally, KBC Group NV bought a new position in shares of Phibro Animal Health Corporation during the second quarter worth $166,000. Hedge funds and other institutional investors own 48.35% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/31/phibro-animal-health-corporation-pahc-posts-earnings-results-beats-expectations-by-0-04-eps.html.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Earnings History for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Stock Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related stocks with our FREE daily email newsletter.